Kovitz Investment Group Partners, LLC Abbott Laboratories Transaction History

Kovitz Investment Group Partners, LLC

  • $15 Billion
  • Q3 2024

A detailed history of Kovitz Investment Group Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 250,254 shares of ABT stock, worth $28.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
250,254
Previous 173,378 44.34%
Holding current value
$28.1 Million
Previous $18 Million 58.37%
% of portfolio
0.19%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$100.07 - $118.13 $7.69 Million - $9.08 Million
76,876 Added 44.34%
250,254 $28.5 Million
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $1.6 Million - $1.79 Million
15,890 Added 10.09%
173,378 $18 Million
Q1 2024

May 14, 2024
BUY
$109.52 - $120.96 $7.18 Million - $7.93 Million
65,596 Added 71.38%
157,488 $17.9 Million
Q4 2023

Feb 07, 2024
SELL
$90.19 - $110.4 $88,837 - $108,744
-985 Reduced 1.06%
91,892 $10.1 Million
Q3 2023

Nov 09, 2023
SELL
$95.53 - $114.62 $670,238 - $804,173
-7,016 Reduced 7.02%
92,877 $9 Million
Q2 2023

Aug 08, 2023
BUY
$100.78 - $112.29 $12,496 - $13,923
124 Added 0.12%
99,893 $10.9 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $281,862 - $331,769
2,910 Added 3.0%
99,769 $10.1 Million
Q4 2022

Jan 19, 2023
SELL
$95.06 - $111.52 $392,597 - $460,577
-4,130 Reduced 4.09%
96,859 $10.6 Million
Q3 2022

Nov 09, 2022
SELL
$96.76 - $112.03 $445,773 - $516,122
-4,607 Reduced 4.36%
100,989 $9.77 Million
Q2 2022

Aug 02, 2022
BUY
$102.07 - $123.37 $24,905 - $30,102
244 Added 0.23%
105,596 $11.5 Million
Q1 2022

Apr 22, 2022
BUY
$114.02 - $139.04 $1.51 Million - $1.84 Million
13,208 Added 14.33%
105,352 $12.5 Million
Q4 2021

Feb 04, 2022
SELL
$115.53 - $141.46 $1.4 Million - $1.71 Million
-12,087 Reduced 11.6%
92,144 $10.1 Million
Q3 2021

Oct 28, 2021
SELL
$116.66 - $129.06 $115,843 - $128,156
-993 Reduced 0.94%
104,231 $12.3 Million
Q2 2021

Aug 04, 2021
BUY
$105.79 - $124.53 $1.43 Million - $1.68 Million
13,476 Added 14.69%
105,224 $12.2 Million
Q1 2021

May 06, 2021
SELL
$108.84 - $128.23 $43,100 - $50,779
-396 Reduced 0.43%
91,748 $11 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $249,480 - $271,861
-2,376 Reduced 2.51%
92,144 $10.1 Million
Q3 2020

Nov 10, 2020
SELL
$91.64 - $111.29 $181,355 - $220,242
-1,979 Reduced 2.05%
94,520 $10.3 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $956,742 - $1.22 Million
-12,495 Reduced 11.46%
96,499 $8.82 Million
Q1 2020

May 15, 2020
BUY
$62.82 - $91.86 $44,727 - $65,404
712 Added 0.66%
108,994 $8.6 Million
Q4 2019

Feb 13, 2020
SELL
$78.51 - $87.4 $228,464 - $254,334
-2,910 Reduced 2.62%
108,282 $9.41 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $395,369 - $428,702
-4,831 Reduced 4.16%
111,192 $9.3 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $2.97 Million - $3.47 Million
-40,796 Reduced 26.01%
116,023 $9.76 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $580,087 - $701,325
-8,760 Reduced 5.29%
156,819 $12.5 Million
Q4 2018

Feb 14, 2019
BUY
$65.56 - $74.27 $8.76 Million - $9.92 Million
133,619 Added 418.08%
165,579 $12 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $138,585 - $167,187
-2,279 Reduced 6.66%
31,960 $2.35 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $15,831 - $17,473
-275 Reduced 0.8%
34,239 $2.09 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $360,465 - $407,549
-6,406 Reduced 15.65%
34,514 $2.07 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $73,273 - $78,446
-1,365 Reduced 3.23%
40,920 $2.34 Million
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $2.03 Million - $2.27 Million
42,285
42,285 $2.26 Million

Others Institutions Holding ABT

# of Institutions
3,189
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email